Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
about
Performance of repetitive tasks induces decreased grip strength and increased fibrogenic proteins in skeletal muscle: role of force and inflammationAeroparticles, Composition, and Lung DiseasesUnravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffnessHIPK2 is a new drug target for anti-fibrosis therapy in kidney diseaseTaking aim at the extracellular matrix: CCN proteins as emerging therapeutic targetsCucurbitacin I Attenuates Cardiomyocyte Hypertrophy via Inhibition of Connective Tissue Growth Factor (CCN2) and TGF- β/Smads SignalingsTGFβ and CCN2/CTGF mediate actin related gene expression by differential E2F1/CREB activation.Self-assembled Micelle Interfering RNA for Effective and Safe Targeting of Dysregulated Genes in Pulmonary FibrosisIncreased Expression of Connective Tissue Growth Factor (CTGF) in Multiple Organs After Exposure of Non-Human Primates (NHP) to Lethal Doses of Radiation.AEOL 10150 Mitigates Radiation-Induced Lung Injury in the Nonhuman Primate: Morbidity and Mortality are Administration Schedule-Dependent.Follistatin like-1 aggravates silica-induced mouse lung injuryFibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosisAnti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosisInhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesisRecent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation.Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation.Pathobiology of liver fibrosis: a translational success storyPatients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-β1, and vascular endothelial growth factor.Induction of thoracic aortic remodeling by endothelial-specific deletion of microRNA-21 in mice.Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.Angiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II.Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathyIntronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis.Adiponectin attenuates lung fibroblasts activation and pulmonary fibrosis induced by paraquat.Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines.Connective tissue growth factor stimulates the proliferation, migration and differentiation of lung fibroblasts during paraquat-induced pulmonary fibrosisCCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis.Radix puerariae extracts ameliorate paraquat-induced pulmonary fibrosis by attenuating follistatin-like 1 and nuclear factor erythroid 2p45-related factor-2 signalling pathways through downregulation of miRNA-21 expressionRenal interstitial fibrosis: mechanisms and evaluation.Precision renal medicine: a roadmap towards targeted kidney fibrosis therapies.Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model.Simultaneous deletion of Bax and Bak is required to prevent apoptosis and interstitial fibrosis in obstructive nephropathyDeletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury.Pharmacologic therapies for idiopathic pulmonary fibrosis, past and future.Smad3-dependent CCN2 mediates fibronectin expression in human skin dermal fibroblasts.CCN2 is required for recruitment of Sox2-expressing cells during cutaneous tissue repair.A review of current and novel therapies for idiopathic pulmonary fibrosisHDAC inhibitors in experimental liver and kidney fibrosis.CTGF mediates Smad-dependent transforming growth factor β signaling to regulate mesenchymal cell proliferation during palate development.TGF-β1 and TGF-β2 abundance in liver diseases of mice and men
P2860
Q23920950-0D56DC42-3E23-4F7C-A7B7-E05B19C5A9ABQ26772710-D9D1FD0C-F5C7-4678-A41A-C9A4792D614EQ26801739-4E434345-97D8-4255-B9A2-ED067452D1D1Q26996407-F24821BA-B17C-4FC5-BB92-E60A37FA9595Q28254386-DE3A5B8B-B2C9-4996-B535-A754EAB484E6Q28547428-BC2A0BFA-B64D-4387-B5D3-9485811CF7E0Q30544203-AF1FC7E7-CF5C-4124-93EA-587AA32061CCQ30734485-31DCA827-24EF-40E9-B52F-E0D02444809DQ33390722-80791B6B-9FD3-44EA-A094-140A1BA6AB70Q33390835-86FADFEE-8135-4A89-A497-7BEA362FAF02Q33672045-A5F92B9F-54E0-494A-A532-0833A98D36EFQ33698776-203CB677-50AB-4E0C-BD29-197ADCA5AD37Q33795658-A88324FC-9023-46FC-A7EB-F2BBD7635417Q33906324-E887EADE-5555-4D87-A8ED-1FFDE4AAAFCBQ34289498-D3390DF0-936F-41A6-991D-E6B08FCED745Q34295008-943D97ED-11E4-44D9-985C-409D5A236EB6Q34462733-EC7B6404-DD0B-4FC6-9781-C32D894A33BAQ34482573-90EB1D07-CFE9-4F7D-B594-B9E57FD0DE1AQ34634506-B513C2FB-B2AD-4FDE-B02E-6E88B4343B98Q34721223-9A0E363F-80B7-435E-9A77-FC1D768F708EQ35025282-B03DBB91-8D60-45FC-9C5F-C7E3D7F68B43Q35078258-DBD0A4E9-DD21-4085-8308-6B0647651437Q35242533-2E256704-DCD4-440A-B89A-DFBCE3327F71Q35577650-A16A9BD1-1ED3-4A12-8FC7-44AC059CA51CQ35598027-4AF2BF40-9D29-4358-82CA-FD2345243BBCQ35628474-1C3A3058-899A-4D0F-8E35-41F3E3CE2CD0Q35827652-A3222CB9-B8C9-457F-861C-04505343E6C4Q35892077-C2A30120-CA32-4009-B2EF-0CB2F4EF54D5Q35967489-182D3FDC-95E2-4A39-B5E0-936FE82B9997Q36015077-67B5416E-E52D-4B5C-BD62-7D2B5129DC39Q36039430-FEDE3309-D67E-4F65-A3A2-9DB5F82FAA16Q36066400-83C32C4C-A60C-4E28-95F3-7AC0645AA2CAQ36163662-C946833A-5DE6-4B02-8250-1F4276D84B0DQ36264068-1EB3041C-9DF7-4BC4-86C8-E493E63270B4Q36299449-6203720F-A969-4AE3-AE2F-C0F523EAE477Q36470952-7AE3C2ED-F1DF-4371-9111-5EF34E2A5BADQ36542274-D3C96D5F-A355-43B8-9A32-FD05D668328EQ36588493-CCFE75FF-B3CA-4DA2-948E-96D138726C44Q37122742-BECCE73F-245E-4117-8A0A-92A4FA24AEC0Q37190089-ECD1325F-D125-406A-8727-C22FC4BF51D3
P2860
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
@ast
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
@en
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
@nl
type
label
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
@ast
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
@en
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
@nl
prefLabel
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
@ast
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
@en
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
@nl
P2093
P2860
P356
P1476
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
@en
P2093
Blake Nichols
David Yeowell
Guangjie Guo
Julia Gray
Mitch Brenner
Noelynn Oliver
Qingjian Wang
Todd W Seeley
P2860
P2888
P356
10.1186/1755-1536-4-4
P577
2011-02-01T00:00:00Z
P5875
P6179
1010726420